HIV-1 Persistence in the CNS and Myeloid Cells

描述（由申请方提供）：很明显，HIV-1可以在CNS中建立一个独立复制的群体，这也可以导致嗜巨噬细胞HIV-1的进化，定义为进入低水平CD 4细胞的能力。然而，受感染细胞在脑中的分布和嗜巨噬细胞病毒在CNS外的出现都是有争议的，这两点都是确定根除HIV-1策略的重要考虑因素。我们对病毒种群的理解已经得到了显着改善，最近广泛承认，PCR介导的重组可以扰乱系统发育信息，并在PCR（单基因组扩增）中使用模板终点稀释是必不可少的，以准确地定义病毒种群。类似地，在模拟进化过程的程序中的改进使得系统发育关系的评估更加鲁棒，例如结合贝叶斯分析程序BEAST。最后，对细胞进入的CD 4依赖性的定量描述提供了比使用高度可变的单核细胞衍生的巨噬细胞制备物来尝试表型已经进化为使用低水平的CD 4进入细胞的病毒更稳健的巨噬细胞嗜性定义。我们正在应用所有这三个重要的进展，以了解嗜巨噬细胞病毒的演变及其在发病机制中的作用，并了解它们创造一个长寿水库的潜力。我们最近将这些工具结合起来研究病毒区室化，包括通过检查CSF中的病毒来研究CNS中的区室化。我们现在已经将这些研究扩展到包括来自国家神经艾滋病组织联盟（NNTC）的样本。我们建议利用这些样本的可用性，在尸检前和尸检时，绘制受试者大脑中病毒复制的位点，这些受试者是病毒血症患者和接受治疗的患者。我们还将确定嗜巨噬细胞病毒在大脑复制中心的作用，以及这种类型的进化变异体在CNS外建立的能力。最后，我们将检查治疗中止后出现的早期反弹病毒的表型，因为这代表了根除策略必须面对的第一个病毒。

DESCRIPTION (provided by applicant): It is clear that HIV-1 can establish an independently replicating population in the CNS, and that this can also lead to the evolution of macrophage-tropic HIV-1, defined as the ability to enter cells with low levels of CD4. However, the distributin of infected cells in the brain and the occurrence of macrophage-tropic virus outside of the CNS are both controversial and both of these points are important considerations in defining strategies for the eradication of HIV-1. Our understanding of viral populations has been significantly improved with the recent widespread acknowledgement that PCR-mediated recombination can scramble phylogenetic information, and that the use of template end-point dilution in PCR (single genome amplification) is essential to define viral populations accurately. Similarly, improvements in programs modeling evolutionary processes make the assessment of phylogenetic relationships more robust, for example incorporating the Bayesian analysis program BEAST. Finally, quantitative descriptions of CD4 dependence for cell entry provide a much more robust definition of macrophage tropism than using highly variable monocyte-derived macrophage preparations to try to phenotype viruses that have evolved to use low levels of CD4 to enter cells. We are applying all three of these important advances to understand the evolution of macrophage-tropic viruses and their role in pathogenesis and to understand their potential to create a long-lived reservoir. We have recently brought these tools together to study viral compartmentalization, including compartmentalization in the CNS by examining virus in the CSF. We have now extended these studies to include samples from the National NeuroAIDS Tissue Consortium (NNTC). We propose to exploit the availability of these samples, taken both prior to and at autopsy, to map the sites of viral replication in the brain in subjects how are viremic and those on therapy. We will also define the role of macrophage-tropic virus in populating centers of replication in the brain, and the ability of this type of evolutionary variant to become established outside of the CNS. Finally, we will examine the phenotype of the early rebound virus that appears after therapy discontinuation, as this represents the first virus that eradication strategies must confront.